Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a
Clinical trial NCT02646371 · COMPLETED
Trial details
- NCT number
- NCT02646371
- Sponsor
- LimmaTech Biologics AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-09-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.